Company Overview and News

 
How Fall of the Dollar Is Impacting Precious Metals and Miners

2018-04-17 marketrealist
One of the market indicators for gold that has been consistently playing a significant role in the determination of the directional move for precious metals is the US dollar, depicted by the Dollar Index (or DXY). It prices the dollar against a basket of six major world currencies. The dollar has fallen 2.9% since the beginning of 2018. During that time, gold has risen 3.3%. The other three precious metals have fallen.

1
US Inflation Rises: How Will It Impact Gold Prices?

2018-04-16 marketrealist
According to the US Bureau of Labor Statistics, the US consumer price index (or CPI) rose 2.4% year-over-year (or YoY) in March 2018. This is its fastest pace in the last 12 months. The core CPI, which excludes volatile food and energy components, rose 0.2% over the previous month and 2.1% YoY in March. This was the biggest gain in core prices since February 2017.

 
Reading the Movements of Miners’ Correlations with Gold

2018-04-12 marketrealist
In this part of our series, we’ll look at the correlation between gold and four mining stocks: Royal Gold (RGLD), Goldcorp (GG), Sibanye Gold (SBGL), and Gold Fields (GFI). Mining stocks mostly move with gold prices, but not always. Among these four miners, Gold Fields has shown the highest correlation with gold, while Royal Gold has seen the lowest correlation with gold on a YTD (year-to-date) basis.

 
Precious Metal Miners and Their Technicals

2018-04-11 marketrealist
Usually, precious metal mining companies closely follow precious metals. All four precious metals except platinum saw their prices rise on Tuesday, April 10, 2018.

 
What Mining Stocks’ Relative Strength Index Tells You

2018-04-09 marketrealist
The precious metals and miners were widely expected to react negatively after the Fed decided to hike interest rates.

 
Gold Road starts work on $23m greenfields campaign

2018-04-06 australianmining.com.au
Gold Road Resources has launched its $23 million 2018 greenfields exploration drilling campaign in Western Australia.

1
Gold Mining Bull: Top News And Month In Review

2018-04-04 seekingalpha
Here's a monthly recap of the top news in the gold mining sector, including drill results, takeover announcements and other relevant updates, to keep readers up-to-date on news in the sector. Here's my update for February if you missed it.

 
Is an Uptick in Inflation on the Way, Supporting Gold?

2018-04-03 editors.aws.marketrealist
The most recent data for the US Consumer Price Index (or CPI) was weaker than expected. The CPI rose 0.2% in February 2018, compared to a 0.5% rise in January 2018.

 
Deals of the day-Mergers and acquisitions

2018-03-29 reuters
March 29 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:

 
How the Dollar’s Rebound Affected Gold and Other Precious Metals

2018-03-29 editors.aws.marketrealist
A crucial factor that could be behind the loss in precious metals on Wednesday was the rebound in the US dollar. The US Dollar Index, which is depicted by the DXY Currency Index (UUP), increased 0.82% on Wednesday. It also stands at a five-day trailing gain of 0.31%. The rise of the US dollar is often detrimental for precious metals, as they are all dollar-denominated assets. The higher the dollar, the more expensive it gets for buyers from other countries to invest in dollar and dollar assets.

 
GDXJ: The Market's Best Risk Play?

2018-03-29 seekingalpha
Dividend stocks work well in these environments, but income portfolios will also need some added measure of safety if further “flash crashes” are seen this year.

 
The Correlation of Miners So Far in March

2018-03-28 editors.aws.marketrealist
Mining stocks tend to move in accordance with gold prices. In this final part of the series, we’ll analyze the correlation between gold and four mining stocks: First Majestic Silver (AG), B2Gold (BTG), Gold Fields (GFI), and Agnico-Eagle Mines (AEM). Among the miners under consideration, Gold Fields has the highest correlation with gold, while B2Gold has the lowest correlation.

 
US Inflation Softens, Gold Still Has Drivers to the Upside

2018-03-26 editors.aws.marketrealist
As per the U.S. Bureau of Labor Statistics, the US Consumer Price Index (or CPI) rose 0.2% in February, compared to a 0.5% rise in January 2018. This inflation figure was in line the market expectation of a 0.2% rise. The year-over-year (or YoY) rise in inflation came in at 1.8% for February 2018, also in line with expectations. The softer inflation figure in February is also in line with the weaker-than-expected growth in wages during the month.

 
Why Physical Gold Demand Should Support Gold Prices in 2018

2018-03-26 editors.aws.marketrealist
According to the World Gold Council (or WGC), the demand for physical gold in 4Q17 increased 20% sequentially. The demand for gold jewelry increased 4% in 2017, which was the first annual rise since 2013.

 
How the Lower US Dollar Is Affecting Gold and Miners

2018-03-26 editors.aws.marketrealist
On March 23, gold touched a two-week high and closed at $1,349.30 per ounce, and silver ended the day at $16.50 per ounce. The metals likely rose due to the US dollar falling. The US dollar, depicted by the DXY Currency Index (UUP), fell 0.42% on Friday and had fallen 0.83% in the last five days.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...